» Articles » PMID: 29377634

In Immunopeptidomics We Need a Sniper Instead of a Shotgun

Overview
Journal Proteomics
Date 2018 Jan 30
PMID 29377634
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Immunopeptidomics employs the use of mass spectrometry to identify and quantify peptides presented on the surface of cells by major histocompatibility complex (MHC; human leukocyte antigen [HLA], in humans) molecules, an essential component of adaptive immunity. Currently, immunopeptidomics follows the same or similar workflows as the more established field of shotgun proteomics, yet inherent differences between these two fields create significant drawbacks for the former. In this viewpoint, we would like to highlight such technical issues and provide suggestions for novel workflows that would increase peptide sequencing coverage, depth, and confidence, collectively enhancing the capabilities of the field of immunopeptidomics.

Citing Articles

Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics.

Velz J, Freudenmann L, Medici G, Dubbelaar M, Mohme M, Ghasemi D Nat Commun. 2025; 16(1):1364.

PMID: 39904979 PMC: 11794601. DOI: 10.1038/s41467-025-56268-0.


Ribosome profiling shows variable sensitivity to detect open reading frames for conventional and different types of cryptic T cell antigens.

Fuchs K, Thomaidou S, van der Slik A, van de Meent M, t Hoen P, Falkenburg J Mol Ther Methods Clin Dev. 2025; 33(1):101391.

PMID: 39811688 PMC: 11731205. DOI: 10.1016/j.omtm.2024.101391.


Validation and quantification of peptide antigens presented on MHCs using SureQuant.

Leddy O, Cui Y, Ahn R, Stopfer L, Choe E, Kim D Nat Protoc. 2024; .

PMID: 39438697 DOI: 10.1038/s41596-024-01076-x.


Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation.

Juanes-Velasco P, Arias-Hidalgo C, Garcia-Vaquero M, Sotolongo-Ravelo J, Paino T, Lecrevisse Q Int J Mol Sci. 2024; 25(17).

PMID: 39273511 PMC: 11395153. DOI: 10.3390/ijms25179564.


Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum.

Ingels J, De Cock L, Stevens D, Mayer R, Thery F, Sanchez Sanchez G Cell Rep Med. 2024; 5(5):101516.

PMID: 38626769 PMC: 11148567. DOI: 10.1016/j.xcrm.2024.101516.